Contrasting Akso Health Group (NASDAQ:AHG) & Accolade (NASDAQ:ACCD)

Accolade (NASDAQ:ACCD – Get Free Report) and Akso Health Group (NASDAQ:AHG – Get Free Report) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Valuation & Earnings

This table compares Accolade and Akso Health Group”s revenue, earnings per share (EPS) and valuation.

Akso Health Group has lower revenue, but higher earnings than Accolade.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Accolade and Akso Health Group, as provided by MarketBeat.

Accolade presently has a consensus target price of $7.65, suggesting a potential upside of 11.52%. Given Accolade’s stronger consensus rating and higher possible upside, analysts plainly believe Accolade is more favorable than Akso Health Group.

Profitability

This table compares Accolade and Akso Health Group’s net margins, return on equity and return on assets.

Risk & Volatility

Accolade has a beta of 2.08, suggesting that its stock price is 108% more volatile than the S&P 500. Comparatively, Akso Health Group has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500.

Insider and Institutional Ownership

85.0% of Accolade shares are owned by institutional investors. Comparatively, 1.2% of Akso Health Group shares are owned by institutional investors. 8.2% of Accolade shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Accolade beats Akso Health Group on 7 of the 12 factors compared between the two stocks.

About Accolade

(Get Free Report)

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

About Akso Health Group

(Get Free Report)

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Receive News & Ratings for Accolade Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Accolade and related companies with MarketBeat.com’s FREE daily email newsletter.